HomeCompareLAZR vs JNJ

LAZR vs JNJ: Dividend Comparison 2026

LAZR yields 3215.43% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LAZR wins by $881435314030.58M in total portfolio value
10 years
LAZR
LAZR
● Live price
3215.43%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$881435314030.61M
Annual income
$830,619,345,475,207,800.00
Full LAZR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LAZR vs JNJ

📍 LAZR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLAZRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LAZR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LAZR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LAZR
Annual income on $10K today (after 15% tax)
$273,311.90/yr
After 10yr DRIP, annual income (after tax)
$706,026,443,653,926,700.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LAZR beats the other by $706,026,443,653,922,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LAZR + JNJ for your $10,000?

LAZR: 50%JNJ: 50%
100% JNJ50/50100% LAZR
Portfolio after 10yr
$440717657015.32M
Annual income
$415,309,672,737,606,300.00/yr
Blended yield
94.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LAZR
Analyst Ratings
7
Buy
6
Hold
2
Sell
Consensus: Buy
Price Target
$86.00
+138163.7% upside vs current
Range: $3.00 — $315.00
Altman Z
-34.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LAZR buys
0
JNJ buys
0
No recent congressional trades found for LAZR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLAZRJNJ
Forward yield3215.43%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$881435314030.61M$30.3K
Annual income after 10y$830,619,345,475,207,800.00$4,689.40
Total dividends collected$877934535250.88M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$86.00$228.73

Year-by-year: LAZR vs JNJ ($10,000, DRIP)

YearLAZR PortfolioLAZR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$332,243$321,543.41$10,592$272.30+$321.7KLAZR
2$10,339,676$9,984,175.51$11,289$357.73+$10.33MLAZR
3$301,451,666$290,388,212.74$12,123$472.89+$301.44MLAZR
4$8,234,911,963$7,912,358,680.17$13,141$629.86+$8234.90MLAZR
5$210,816,979,853$202,005,624,053.21$14,408$846.81+$210816.97MLAZR
6$5,058,680,053,844$4,833,105,885,400.90$16,021$1,151.60+$5058680.04MLAZR
7$113,799,029,350,690$108,386,241,693,076.52$18,122$1,588.22+$113799029.33MLAZR
8$2,400,488,953,522,890$2,278,723,992,117,652.00$20,930$2,228.20+$2400488953.50MLAZR
9$47,491,559,397,572,490$44,923,036,217,302,990.00$24,792$3,191.91+$47491559397.55MLAZR
10$881,435,314,030,610,300$830,619,345,475,207,800.00$30,274$4,689.40+$881435314030.58MLAZR

LAZR vs JNJ: Complete Analysis 2026

LAZRStock

Luminar Technologies, Inc., an automotive technology company, provides sensor technologies and software for passenger cars and commercial trucks in North America, the Asia Pacific, Europe, and the Middle East. It operates in two segments, Autonomy Solutions and Components. The Autonomy Solutions segment designs, manufactures, and sells laser imaging, detection, and ranging sensors, as well as related perception and autonomy software solutions primarily for original equipment manufacturers in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Component segment develops ultra-sensitive pixel-based sensors. This segment also designs, tests, and provides consulting services for non-standard integrated circuits for use in automobile and aeronautics sector, as well as government spending in military and defense activities. The company was founded in 2012 and is headquartered in Orlando, Florida.

Full LAZR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LAZR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LAZR vs SCHDLAZR vs JEPILAZR vs OLAZR vs KOLAZR vs MAINLAZR vs ABBVLAZR vs MRKLAZR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.